U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512609) titled 'Environment, Inflammation and Metabolic Diseases Study' on Nov. 20, 2025.
Brief Summary: The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover new mechanisms underlying the onset and progression of these diseases, and to screen for novel therapeutic targets.
Study Start Date: Dec. 25, 2020
Study Type: OBSERVATIONAL
Condition:
Endocrine Disease
Metabolic Disorders
Hypertension
Diabetes Mellitus
Intervention:
OTHER: observe
A single observational cohort of study participants undergoing baseline biochemical ...